
Beyond overt risks like obesity and diabetes, your patients with features of metabolic syndrome are at risk for more subtle problems--like infertility, pregnancy loss, and polycystic ovarian syndrome.
DR. PAL is Assistant Professor, Dept. of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New HAven, CT, and Visiting Assistant Professor, Dept. of Obstetrics and Gynecology and Women's Health (Reproductive Endocrinolo

Beyond overt risks like obesity and diabetes, your patients with features of metabolic syndrome are at risk for more subtle problems--like infertility, pregnancy loss, and polycystic ovarian syndrome.

Could menopausal hormone therapy protect some women's hearts, after all, as once thought? The new KEEPS trial aims to clarify that lingering question.

Published: October 1st 2009 | Updated:

Published: August 1st 2009 | Updated: